바이오인

 

Introduction to Green Biotechnology 4
Competitiveness, sustainability and beyond 5

The 5 Problems and Suggested Solutions:
- 1. Implementing the GM crop authorization process effectively 6
- 2. Enabling a European single market in seeds 7
- 3. Respecting other countries’ freedom to trade in commodities 8
- 4. Promoting coherence of policies and public information on green biotech 9
- 5. Promoting coherence of biotech policies with development goals 10

Conclusions: Moving Europe forward

 

 

 

Agricultural or “green” biotechnology is being adopted at record speed around the world. In 2008:

■ 13.3 million farmers in 25 countries cultivated genetically modified (biotech) crops on 125 million hectares1

■ This is a 9.4% increase in global biotech crop acreage compared to 2007, demonstrating that farmers around the world, especially in developing countries where 90% of cultivation
takes place, recognize the benefits plant technology can bring. Planting in Europe is on a smaller scale, but has accelerated over the last 11 years as farmers start realizing the benefits of biotech crops; lower costs and lower mycotoxins levels being the drivers for insect-resistant maize. In 2008:

■107,719 hectares of biotech crops were planted in seven EU countries. The technology is safe and regulatory systems, if applied correctly in the countries of the European Union,
guarantee consumers and farmers the choice of whether to consume and plant GM food and GM crops, respectively.